NO20063809L - Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning - Google Patents

Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning

Info

Publication number
NO20063809L
NO20063809L NO20063809A NO20063809A NO20063809L NO 20063809 L NO20063809 L NO 20063809L NO 20063809 A NO20063809 A NO 20063809A NO 20063809 A NO20063809 A NO 20063809A NO 20063809 L NO20063809 L NO 20063809L
Authority
NO
Norway
Prior art keywords
hydrochloride
venlaflaxin
mini tablets
extended action
coated mini
Prior art date
Application number
NO20063809A
Other languages
English (en)
Norwegian (no)
Inventor
Sampad Bhattacharya
Rajesh Kshirsagar
Mayank Joshi
Sandeep Pandita
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of NO20063809L publication Critical patent/NO20063809L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20063809A 2004-02-04 2006-08-25 Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning NO20063809L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13
PCT/IN2004/000340 WO2005074895A1 (en) 2004-02-04 2004-10-27 Extended release coated microtablets of venlafaxine hydrochloride

Publications (1)

Publication Number Publication Date
NO20063809L true NO20063809L (no) 2006-08-25

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063809A NO20063809L (no) 2004-02-04 2006-08-25 Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning

Country Status (23)

Country Link
US (1) US7807195B2 (pt)
EP (1) EP1711169B1 (pt)
JP (1) JP2007520547A (pt)
KR (1) KR20070000439A (pt)
AT (1) ATE361743T1 (pt)
AU (1) AU2004315136B2 (pt)
BR (1) BRPI0418283A (pt)
CA (1) CA2555295C (pt)
CY (1) CY1106741T1 (pt)
DE (1) DE602004006443T2 (pt)
DK (1) DK1711169T3 (pt)
ES (1) ES2287813T3 (pt)
HR (1) HRP20070353T3 (pt)
IL (1) IL177243A0 (pt)
MX (1) MXPA06008854A (pt)
NO (1) NO20063809L (pt)
NZ (1) NZ548504A (pt)
PL (1) PL1711169T3 (pt)
PT (1) PT1711169E (pt)
RU (1) RU2340331C2 (pt)
SI (1) SI1711169T1 (pt)
UA (1) UA82597C2 (pt)
WO (1) WO2005074895A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003278549A1 (en) * 2002-11-28 2004-06-18 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
WO2007016315A2 (en) * 2005-07-28 2007-02-08 Dr. Reddy's Laboratories Ltd. Extended release venlafaxine compositions
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
US20100120723A1 (en) * 2006-12-20 2010-05-13 Mostafa Akbarieh Pharmaceutical composition comprising a hot-melt granulated lubricant
EP2124963A4 (en) * 2006-12-20 2010-03-17 Mylan Pharmaceuticals Ulc COMPOSITION WITH A BISPHOSPHONIC ACID IN COMBINATION WITH VITAMIN D
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
US9789093B2 (en) 2011-01-31 2017-10-17 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
CN108366989B (zh) 2015-12-25 2020-11-03 富士胶片富山化学株式会社 含有1-(3-(2-(1-苯并噻吩-5-基-)乙氧基)丙基)氮杂环丁-3-醇或其盐的片剂
KR102062052B1 (ko) * 2018-03-20 2020-01-03 일양약품주식회사 베타네콜 서방성 제제 및 이의 제조방법
KR20230067863A (ko) 2021-11-10 2023-05-17 박찬호 스마트 계량도구 및 이를 이용한 요리보조 시스템

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
IL139298A0 (en) * 1998-05-15 2001-11-25 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
WO2001037815A1 (en) 1999-11-22 2001-05-31 Alza Corporation Osmotic dosage form comprising first and second
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
WO2002085335A1 (en) * 2001-04-18 2002-10-31 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
JP2005516020A (ja) 2001-12-20 2005-06-02 ファルマシア・コーポレーション ゼロ次持続放出剤形およびその製造方法
AU2002217373A1 (en) * 2002-01-03 2003-07-15 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003082805A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Low water-soluble venlafaxine salts
US20030191347A1 (en) * 2002-03-28 2003-10-09 Rolf Keltjens Venlafaxine base
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
BR0312445A (pt) * 2002-06-07 2005-05-10 Ranbaxy Lab Ltd Sistemas multiunitários para disponibilização de fármaco de liberação modificada
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1558222A2 (en) * 2002-10-25 2005-08-03 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
EP1596837A2 (en) * 2003-02-07 2005-11-23 Omega Farma Ehf Sustained release formulations of venlafaxine
ATE336988T1 (de) * 2003-07-30 2006-09-15 Pharmathen Sa Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
US20050169985A1 (en) 2005-08-04
UA82597C2 (uk) 2008-04-25
HRP20070353T3 (en) 2008-01-31
AU2004315136B2 (en) 2010-06-17
WO2005074895A1 (en) 2005-08-18
SI1711169T1 (sl) 2007-10-31
IL177243A0 (en) 2006-12-10
MXPA06008854A (es) 2007-01-23
CA2555295A1 (en) 2005-08-18
PT1711169E (pt) 2007-07-23
KR20070000439A (ko) 2007-01-02
ATE361743T1 (de) 2007-06-15
AU2004315136A1 (en) 2005-08-18
US7807195B2 (en) 2010-10-05
RU2340331C2 (ru) 2008-12-10
BRPI0418283A (pt) 2007-05-02
PL1711169T3 (pl) 2007-10-31
ES2287813T3 (es) 2007-12-16
HK1091137A1 (en) 2007-01-12
RU2006129034A (ru) 2008-03-10
DK1711169T3 (da) 2007-09-17
DE602004006443D1 (de) 2007-06-21
DE602004006443T2 (de) 2008-01-10
CY1106741T1 (el) 2012-05-23
EP1711169A1 (en) 2006-10-18
NZ548504A (en) 2009-03-31
CA2555295C (en) 2011-01-18
JP2007520547A (ja) 2007-07-26
EP1711169B1 (en) 2007-05-09

Similar Documents

Publication Publication Date Title
CY1106741T1 (el) Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
PE20050175A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
ATE454138T1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
EA200970267A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
ECSP045409A (es) Composiciones y metodos para dosificar liposomas de ciertos tamaños a fin de tratar o prevenir enfermedades.
MY136136A (en) Pharmaceutical compositions containing terbinafin and use thereof
CY1106693T1 (el) Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη
AR032730A1 (es) Desnaturalizantes para las sales aminas simpaticomimeticas
UY25234A1 (es) Formulación de liberación prolongada de venlafaxina
PE20081106A1 (es) Comprimidos pediatricos de capecitabina
ES2305567T3 (es) Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas.
CO6351711A2 (es) Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
EA200600156A1 (ru) Пероральная дозировочная форма саквинавирмезилата
UY38028A (es) Combinación farmacéutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y su uso para el tratamiento del dolor
EA200500175A1 (ru) Соль морфин-6-глюкуронида
AR040764A1 (es) Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina
AR067502A1 (es) Pelets de administracion oral y liberacion retardada de clorhidrato de duloxetina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application